Franklin Resources Has Lowered Vantiv (VNTV) Position by $3.01 Million; Stock Were Volatile; Merck & Co New Com (MRK) Market Valuation Declined While Stralem & Co Boosted Stake by $450,520

May 27, 2018 - By Michael Collier

Merck & Co., Inc. (NYSE:MRK) Logo

Franklin Resources Inc decreased its stake in Vantiv Inc (VNTV) by 3.37% based on its latest 2017Q4 regulatory filing with the SEC. Franklin Resources Inc sold 41,300 shares as the company’s stock 0.00% . The institutional investor held 1.19M shares of the miscellaneous company at the end of 2017Q4, valued at $87.23M, down from 1.23M at the end of the previous reported quarter. Franklin Resources Inc who had been investing in Vantiv Inc for a number of months, seems to be less bullish one the $ market cap company. It closed at $0 lastly. It is down 0.00% since May 27, 2017 and is . It has underperformed by 11.55% the S&P500.




Stralem & Co Inc increased its stake in Merck & Co Inc New Com (MRK) by 2.61% based on its latest 2017Q4 regulatory filing with the SEC. Stralem & Co Inc bought 8,045 shares as the company’s stock declined 4.63% with the market. The institutional investor held 316,084 shares of the health care company at the end of 2017Q4, valued at $17.79 million, up from 308,039 at the end of the previous reported quarter. Stralem & Co Inc who had been investing in Merck & Co Inc New Com for a number of months, seems to be bullish on the $158.97 billion market cap company. The stock decreased 0.07% or $0.04 during the last trading session, reaching $59.09. About 6.67M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since May 27, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Since March 2, 2018, it had 0 insider buys, and 9 sales for $25.45 million activity. $630,401 worth of Vantiv, Inc. Class A (NYSE:VNTV) was sold by Ferris Stephanie on Tuesday, May 15. The insider Heimbouch Mark L sold 47,853 shares worth $3.96 million. Martin Kimberly sold $440,365 worth of Vantiv, Inc. Class A (NYSE:VNTV) on Friday, March 2. TAYLOR MATT also sold $4.46M worth of Vantiv, Inc. Class A (NYSE:VNTV) on Friday, March 2. On Monday, May 21 Drucker Charles sold $6.99 million worth of Vantiv, Inc. Class A (NYSE:VNTV) or 85,000 shares. 14,127 shares were sold by Thompson Christopher A, worth $1.18M.

More recent Vantiv, Inc. Class A (NYSE:VNTV) news were published by: Streetinsider.com which released: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018. Also Streetinsider.com published the news titled: “Loeb’s Third Point LLC Enters Adobe (ADBE), EA (EA), Wynn (WYN) (more…) – 13F” on May 15, 2018. Streetinsider.com‘s news article titled: “Sachem Head Capital Enters ADP (ADP), PagSeguro Digita (PAGS), WorldPay (WP) (more…) – 13F” with publication date: May 15, 2018 was also an interesting one.

Franklin Resources Inc, which manages about $208.39 billion US Long portfolio, upped its stake in Express Scripts Hldg Co (NASDAQ:ESRX) by 12,663 shares to 212,312 shares, valued at $15.85M in 2017Q4, according to the filing. It also increased its holding in Insteel Industries Inc (NASDAQ:IIIN) by 454,320 shares in the quarter, for a total of 1.23 million shares, and has risen its stake in Servicenow Inc (NYSE:NOW).

Investors sentiment decreased to 0.96 in Q4 2017. Its down 0.23, from 1.19 in 2017Q3. It dropped, as 81 investors sold VNTV shares while 104 reduced holdings. 53 funds opened positions while 125 raised stakes. 177.74 million shares or 2.60% less from 182.48 million shares in 2017Q3 were reported. Ahl Prtnrs Llp reported 0.08% stake. Caisse De Depot Et Placement Du Quebec reported 20,440 shares. Bamco stated it has 0.29% of its portfolio in Vantiv, Inc. Class A (NYSE:VNTV). Goldman Sachs Grp Inc invested in 2.25M shares or 0.04% of the stock. Old Mutual Customised Solutions (Proprietary) Ltd has 0.02% invested in Vantiv, Inc. Class A (NYSE:VNTV) for 2,400 shares. Aqr Capital Ltd Limited Liability Company holds 0% of its portfolio in Vantiv, Inc. Class A (NYSE:VNTV) for 50,140 shares. Flossbach Von Storch Ag reported 5.25 million shares. Stonerise Mgmt Limited Liability Com reported 155,000 shares or 15.55% of all its holdings. Nomura Asset Mngmt holds 51,029 shares. Korea has 0.15% invested in Vantiv, Inc. Class A (NYSE:VNTV). Shell Asset Mgmt has invested 0.35% in Vantiv, Inc. Class A (NYSE:VNTV). Moreover, Apg Asset Mgmt Nv has 0.01% invested in Vantiv, Inc. Class A (NYSE:VNTV) for 104,810 shares. First Tru Advisors LP reported 244,935 shares. Ingalls & Snyder Ltd Limited Liability Company holds 0.09% or 28,015 shares. Manufacturers Life Insurance The accumulated 23,037 shares.

Among 38 analysts covering Vantiv Inc (NYSE:VNTV), 26 have Buy rating, 0 Sell and 12 Hold. Therefore 68% are positive. Vantiv Inc has $93.0 highest and $36.0 lowest target. $71.57’s average target is 0.00% above currents $0 stock price. Vantiv Inc had 98 analyst reports since July 31, 2015 according to SRatingsIntel. Jefferies downgraded the stock to “Hold” rating in Thursday, February 9 report. The company was maintained on Tuesday, June 20 by Robert W. Baird. Jefferies upgraded the stock to “Buy” rating in Thursday, December 14 report. The rating was maintained by Citigroup on Friday, August 11 with “Buy”. On Friday, January 8 the stock rating was upgraded by Suntrust Robinson to “Buy”. Stifel Nicolaus upgraded Vantiv, Inc. Class A (NYSE:VNTV) on Thursday, August 10 to “Buy” rating. The stock of Vantiv, Inc. Class A (NYSE:VNTV) earned “Outperform” rating by Wedbush on Friday, December 1. RBC Capital Markets maintained Vantiv, Inc. Class A (NYSE:VNTV) on Wednesday, August 9 with “Buy” rating. The firm earned “Top Pick” rating on Thursday, January 4 by RBC Capital Markets. Oppenheimer maintained Vantiv, Inc. Class A (NYSE:VNTV) rating on Thursday, October 29. Oppenheimer has “Outperform” rating and $55 target.

Stralem & Co Inc, which manages about $2.29 billion and $588.71M US Long portfolio, decreased its stake in Lowes Cos Inc Com (NYSE:LOW) by 18,300 shares to 241,310 shares, valued at $22.43 million in 2017Q4, according to the filing. It also reduced its holding in Amgen Inc Com (NASDAQ:AMGN) by 11,720 shares in the quarter, leaving it with 70,135 shares, and cut its stake in Unitedhealth Group Inc Com (NYSE:UNH).

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.12, from 1.06 in 2017Q3. It fall, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. 40,000 are held by Hudson Bay Cap Mngmt Limited Partnership. Marco Investment Management Ltd owns 0.77% invested in Merck & Co., Inc. (NYSE:MRK) for 90,276 shares. Shikiar Asset Management Incorporated invested 0.78% in Merck & Co., Inc. (NYSE:MRK). Markel invested 0.01% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Dnb Asset Mgmt As holds 0.37% or 539,479 shares. Moreover, Goelzer Investment has 1.01% invested in Merck & Co., Inc. (NYSE:MRK). Inv Partners Limited Oh Adv holds 0.62% or 14,956 shares in its portfolio. Fund Management invested in 0.33% or 1.08 million shares. Whitnell & accumulated 15,125 shares or 0.36% of the stock. Rnc Cap Mgmt Limited Liability Corp accumulated 16,775 shares. Lombard Odier Asset Mngmt (Switzerland) Sa holds 9,625 shares. Hm Payson & Co stated it has 0.86% of its portfolio in Merck & Co., Inc. (NYSE:MRK). West Chester Advsrs Incorporated has 0.26% invested in Merck & Co., Inc. (NYSE:MRK) for 4,954 shares. Motco invested 0.33% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Miles Capital has invested 0.16% of its portfolio in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Market Perform” rating by Leerink Swann given on Monday, October 23. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Piper Jaffray on Friday, July 28. As per Thursday, August 27, the company rating was upgraded by Berenberg. The rating was upgraded by BNP Paribas on Tuesday, August 18 to “Outperform”. The rating was downgraded by Jefferies to “Underperform” on Monday, December 19. On Monday, April 23 the stock rating was upgraded by Goldman Sachs to “Buy”. The firm earned “Hold” rating on Monday, October 30 by SunTrust. The stock has “Buy” rating by BMO Capital Markets on Tuesday, June 6. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating on Tuesday, January 16. Jefferies has “Hold” rating and $55.0 target. The stock of Merck & Co., Inc. (NYSE:MRK) has “Outperform” rating given on Thursday, October 12 by BMO Capital Markets.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Bizjournals.com which released: “Why Big Pharma is finally discovering the Bay Area” on May 23, 2018, also 247Wallst.com with their article: “Major Pharma Short Sellers Grow More Selective” published on May 25, 2018, Streetinsider.com published: “Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)” on May 24, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: 247Wallst.com and their article: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” published on April 30, 2018 as well as Seekingalpha.com‘s news article titled: “Merck: Getting Stronger” with publication date: May 04, 2018.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: